Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
Clinical trial NCT04816526 · TERMINATED
Trial details
- NCT number
- NCT04816526
- Sponsor
- Cartesian Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-08-04
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.